Dermatologic Disease
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
PEEL TherapeuticsUT - Salt Lake City
1 programAddressing Inequity in DermatologyN/A1 trial
Active Trials
IncyteDE - Wilmington
1 programVitiligo Registry for Adults and Children in the UKN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
IncyteVitiligo Registry for Adults and Children in the UK
PEEL TherapeuticsAddressing Inequity in Dermatology
Clinical Trials (2)
Total enrollment: 30 patients across 2 trials
Vitiligo Registry for Adults and Children in the UK
Start: May 2026Est. completion: Feb 203030 patients
N/ANot Yet Recruiting
Addressing Inequity in Dermatology
Start: Aug 2023Est. completion: Apr 2026
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 30 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.